News

Clarity and Nucleus RadioPharma sign Master Services Agreement and Cu-67 SAR-bisPSMA Clinical Supply Agreement

AstraZeneca-backed CDMO Nucleus RadioPharma to boost commercial capacity

Nucleus RadioPharma Expands Radiopharmaceutical Research, Development and Manufacturing Capacity, Addressing Nationwide Supply Chain Constraints

Expanding Radiopharmaceuticals for Cancer Treatment: Addressing Supply and Manufacturing Challenges – Charles Conroy

Nucleus RadioPharma CEO Chuck Conroy featured In C&EN article: Investment grows in radiopharma manufacturing

Nucleus RadioPharma Secures Series A Extension Funding with AstraZeneca Investment

CDMO Nucleus RadioPharma links up with ARTBIO to help produce prostate cancer candidate for clinical trials

ARTBIO and Nucleus RadioPharma Announce Collaboration to Manufacture GMP-Grade Therapeutic Products Containing Radioisotope Pb-212 to Support Emerging Clinical Trials

Nucleus RadioPharma Announces Appointment of Chris McDonald from Kite, a Gilead Company, to Board of Directors

Eckert & Ziegler to Supply Nucleus RadioPharma with Therapeutic Radioisotopes Ac-225 and Lu-177